您也可能阅读
通过共同作者、期刊和引用图与本文相关的文章。
Soukaina Amniouel1, Keertana Yalamanchili1,2, Sreenidhi Sankararaman1,3
1School of System Biology, George Mason University, Fairfax, VA 22030, USA.
这项研究确定了用于预测血清性卵巢癌 (SOC) 患者对基化疗反应的关键基因生物标志物. 开发的模型达到90%以上的准确性,有助于个性化癌症治疗策略.
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: